19th Annual Pain Therapeutics

13 May - 14 May, 2019

ssapal@smi-online.co.uk

+44 (0)20 7827 6000

http://go.evvnt.com/348163-0?pid=5394

Copthorne Tara Hotel , United Kingdom

Organized By:

SMi Group

+44 (0)20 7827 6000

events@smi-online.co.uk

https://www.smi-online.co.uk/

King's Rd, Haslemere GU27 2QH, United Kingdom

About 19th Annual Pain Therapeutics

The SMi Group is delighted to announce it's 19th Annual Pain Therapeutics conference which will be held in London on the 13th and 14th May 2019.

The global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, postsurgical pain, arthritis, and fibromyalgia, is driving growth.

Join Europe's leading Pain Therapeutics Conference which will explore the cutting edge research of novel therapeutic targets in the pipeline of leading pharmaceutical companies and discuss solutions for the challenges of clinical trial design and conduct.

New case studies and regulatory perspectives will bring together the challenges and successes of both pre-clinical and clinical development to equip you with the necessary knowledge to advance the pain therapeutic industry.

Speakers

Speaker

More...

Visitors Profile

Amgen; Aptinyx; Arthritis Research UK; Asahi Kasei Corporation; AstraZeneca; Bayer AG; BenevolentAI; Cellectricon; Centrexion Therapeutics Corp.; Chdr; Clermont Universit; Danish Headache Centre; Drug Discovery Today; Eli Lilly & Co; Eli Lilly and Company; Eupraxia Pharmaceuticals; Flexion Therapeutics; Gr³nenthal Group; Grunenthal Gmb H; Innopain; Ipsen; Ipsen Biopharma; Iptechex Pharmalicensing; Lotus Clinical Research, Llc; MD Biosciences; Medherant Limited; Merck Research Laboratories; Metys Pharmaceuticals; MHRA; MSD; Mundipharma International; Mundipharma International Ltd; Novartis Pharmaceuticals; Orion Pharma; Orion Pharma (UK) Ltd; Pharmaleads; Pierre Fabre France; Premier Research; Premier Research Gemany Ltd.; Premier Research Group; Semnur Pharmaceuticals; THE ANN HAYES CONSULTANCY; Viromed;

Event Partners

More...